Vitamin D receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats

International Journal of Endocrinology

Volumn 2010, Issue , 2010, Pages

  Wu Wong, J Ruth ^a   Noonan, William ^b   Nakane, Masaki ^c   Brooks, Kristin A ^b   Segreti, Jason A ^b   Polakowski, James S ^b   Cox, Bryan ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ABBOTT LABORATORIES   (United States)

^c VidaGene   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CINACALCET; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; PARATHYROID HORMONE; PARICALCITOL; PHENYLEPHRINE; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM; HEART RATE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; UREMIA;

EID: 79952206275     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2010/625852     Document Type: Article

References (39)

1. Zebrack J. S., Anderson J. L., Beddhu S., Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? Journal of (Pubitemid 36760761)
2. Weiner D. E., Tighiouart H., Amin M. G., Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies Journal of the American Society of Nephrology 2004 15 5 1307 1315 (Pubitemid 38526012)
3. Callera G., Tostes R., Savoia C., Muscara M. N., Touyz R. M., Vasoactive peptides in cardiovascular (patho)physiology Expert Review of Cardiovascular Therapy 2007 5 3 531 552 (Pubitemid 46805580)
4. Oliver J. J., Webb D. J., Newby D. E., Stimulated tissue plasminogen activator release as a marker of endothelial function in humans Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 12 2470 2479 (Pubitemid 43732266)
5. Libby P., Aikawa M., Jain M. K., Vascular endothelium and atherosclerosis Handbook of Experimental Pharmacology 2006 176 285 306
6. Fltou M., Vanhoutte P. M., Endothelial dysfunction: a multifaceted disorder American Journal of Physiology 2006 291 3 H985 H1002
7. Ochodnicky P., Vettoretti S., Henning R. H., Buikema H., van Dokkum P. E., de Zeeuw D., Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response Journal of Nephrology 2006 19 3 246 258 (Pubitemid 46785535)
8. Virdis A., Ghiadoni L., Versari D., Giannarelli C., Salvetti A., Taddei S., Endothelial function assessment in complicated hypertension Current Pharmaceutical Design 2008 14 18 1761 1770 (Pubitemid 351998580)
9. Caballero A. E., Arora S., Saouaf R., Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 1999 48 9 1856 1862 (Pubitemid 29415208)
10. Levin A., Bakris G. L., Molitch M., Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney International 2007 71 1 31 38 (Pubitemid 44967731)
11. Wu-Wong J. R., Endothelial dysfunction and chronic kidney disease: treatment options Current Opinion in Investigational Drugs 2008 9 9 970 982
12. Wu-Wong J. R., Potential for vitamin D receptor agonists in the treatment of cardiovascular disease British Journal of Pharmacology 2009 158 2 395 412
13. Martin K. J., Gonzlez E. A., Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism Seminars in Nephrology 2004 24 5 456 459 (Pubitemid 39361053)
14. Teng M., Wolf M., Lowrie E., Ofsthun N., Lazarus J. M., Thadhani R., Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy The New England Journal of Medicine 2003 349 5 446 456 (Pubitemid 36910023)
15. Teng M., Wolf M., Ofsthun M. N., Activated injectable vitamin D and hemodialysis survival: a historical cohort study Journal of the American Society of Nephrology 2005 16 4 1115 1125 (Pubitemid 41710323)
16. Kalantar-Zadeh K., Kuwae N., Regidor D. L., Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney International 2006 70 4 771 780 (Pubitemid 44215354)
17. Hyung W. K., Cheol W. P., Young S. S., Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis Nephron Clinical Practice 2006 102 1 C21 C29
18. Wolf M., Shah A., Gutierrez O., Vitamin D levels and early mortality among incident hemodialysis patients Kidney International 2007 72 8 1004 1013 (Pubitemid 47530570)
19. Andress D. L., Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation Kidney International 2006 69 1 33 43 (Pubitemid 43117736)
20. Ebert R., Schtze N., Adamski J., Jakob F., Vitamin D signaling is modulated on multiple levels in health and disease Molecular and Cellular Endocrinology 2006 248 1-2 149 159
21. Gschwend S., Buikema H., Navis G., Henning R. H., de Zeeuw D., van Dokkum R. P. E., Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat Journal of the American Society of Nephrology 2002 13 12 2909 2915 (Pubitemid 35386910)
22. Ghosh S. S., Krieg R. J., Sica D. A., Wang R., Fakhry I., Gehr T., Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system Pediatric Nephrology 2009 24 2 367 377
23. Mizobuchi M., Morrissey J., Finch J. L., Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats Journal of the American Society of Nephrology 2007 18 6 1796 1806 (Pubitemid 46870316)
24. Slatopolsky E., Finch J., Ritter C., A new analog of calcitriol, 19-nor-1,25- (OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia American Journal of Kidney Diseases 1995 26 5 852 860
25. Polakowski J. S., Segreti J. A., Cox B. F., Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats Clinical and Experimental Pharmacology and Physiology 2004 31 12 837 841 (Pubitemid 40052305)
26. Borges A. C. R., Feres T., Vianna L. M., Paiva T. B., Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine Hypertension 1999 34 4 897 901 (Pubitemid 29501320)
27. Wong M. S. K., Delansorne R., Man R. Y. K., Vanhoutte P. M., Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat American Journal of Physiology 2008 295 1 H289 H296
28. Karavalakis E., Erranta A., Vehmas T. I., Paricalcitol treatment and arterial tone in experimental renal insufficiency Nephron Experimental Nephrology 2008 109 3 e84 e93
29. Bodyak N., Ayus J. C., Achinger S., Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals Proceedings of the National Academy of Sciences of the United States of America 2007 104 43 16810 16815 (Pubitemid 350210947)
30. Freundlich M., Quiroz Y., Zhang Z., Suppression of renin-angiotensin gene expression in the kidney by paricalcitol Kidney International 2008 74 11 1394 1402
31. Bortotolotto L. A., Costa-Hong V., Jorgetti V., Vascular changes in chronic renal disease patients with secondary hyperparathyroidism Journal of Nephrology 2007 20 1 66 72
32. Nilsson I.-L., Aberg J., Rastad J., Lind L., Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy Surgery 1999 126 6 1049 1055
33. Jolma P., Koobi P., Kalliovalkama J., Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure Nephrology Dialysis Transplantation 2003 18 12 2560 2569 (Pubitemid 37483789)
34. Noonan W., Koch K., Nakane M., Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats Nephrology Dialysis Transplantation 2008 23 12 3824 3830
35. Wu-Wong J. R., Nakane M., Ma J., Ruan X., Kroeger P. E., Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells American Journal of Physiology 2007 293 5 F1592 F1604
36. Baylis C., Arginine, arginine analogs and nitric oxide production in chronic kidney disease Nature Clinical Practice Nephrology 2006 2 4 209 220 (Pubitemid 43787287)
37. Passauer J., Pistrosch F., Bssemaker E., Lssig G., Herbrig K., Gross P., Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide Journal of the American Society of Nephrology 2005 16 4 959 965 (Pubitemid 41710306)
38. Yamamizu K., Shinozaki K., Ayajiki K., Gemba M., Okamura T., Oral administration of both tetrahydrobiopterin and L-arginine prevents endothelial dysfunction in rats with chronic renal failure Journal of Cardiovascular Pharmacology 2007 49 3 131 139 (Pubitemid 46579946)
39. Wu-Wong J. R., Differential effect of VDR activators on vascular muscle cell gene expression profile pattern Proceedings of the 5th International Symposium Advances in Bone and Mineral Disorders in Chronic Kidney Disease March 2009 Oviedo, Spain